124 related articles for article (PubMed ID: 1409810)
1. Intermittent and continuous cocaine administration: residual behavioral states during withdrawal.
King GR; Joyner C; Lee T; Kuhn C; Ellinwood EH
Pharmacol Biochem Behav; 1992 Sep; 43(1):243-8. PubMed ID: 1409810
[TBL] [Abstract][Full Text] [Related]
2. Continuous or intermittent cocaine administration: effects of amantadine treatment during withdrawal.
King GR; Joyner C; Ellinwood EH
Pharmacol Biochem Behav; 1994 Mar; 47(3):451-7. PubMed ID: 8208762
[TBL] [Abstract][Full Text] [Related]
3. Withdrawal from continuous or intermittent cocaine: behavioral responsivity to 5-HT1 receptor agonists.
King GR; Joyner CM; Ellinwood EH
Pharmacol Biochem Behav; 1993 Jul; 45(3):577-87. PubMed ID: 8332619
[TBL] [Abstract][Full Text] [Related]
4. Blockade of cocaine sensitization and tolerance by the co-administration of ondansetron, a 5-HT3 receptor antagonist, and cocaine.
King GR; Xiong Z; Ellinwood EH
Psychopharmacology (Berl); 1997 Mar; 130(2):159-65. PubMed ID: 9106914
[TBL] [Abstract][Full Text] [Related]
5. Continuous or intermittent cocaine administration: effects of flupenthixol treatment during withdrawal.
King GR; Joyner C; Ellinwood EH
Pharmacol Biochem Behav; 1994 Dec; 49(4):883-9. PubMed ID: 7886102
[TBL] [Abstract][Full Text] [Related]
6. 5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine.
King GR; Joyner CM; Ellinwood EH
Pharmacol Biochem Behav; 1994 Mar; 47(3):399-407. PubMed ID: 8208757
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the expression of sensitization and tolerance by ondansetron, a 5-HT3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine.
King GR; Xiong Z; Ellinwood EH
Psychopharmacology (Berl); 1998 Feb; 135(3):263-9. PubMed ID: 9498729
[TBL] [Abstract][Full Text] [Related]
8. The effects of continuous 5-HT(3) receptor antagonist administration on the subsequent behavioral response to cocaine.
King GR; Pinto G; Konen J; Castro G; Tran S; Hilburn C
Eur J Pharmacol; 2002 Aug; 449(3):253-9. PubMed ID: 12167467
[TBL] [Abstract][Full Text] [Related]
9. Withdrawal from continuous or intermittent cocaine: effects of NAN-190 on cocaine-induced locomotion.
King GR; Joyner C; Lee TH; Ellinwood EH
Pharmacol Biochem Behav; 1993 Feb; 44(2):253-62. PubMed ID: 8446658
[TBL] [Abstract][Full Text] [Related]
10. Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist.
King GR; Xiong Z; Douglass S; Ellinwood EH
Eur J Pharmacol; 2000 Apr; 394(1):97-101. PubMed ID: 10771040
[TBL] [Abstract][Full Text] [Related]
11. Chronic continuous or intermittent infusion of cocaine differentially alter the concentration of neurotensin-like immunoreactivity in specific rat brain regions.
Cain ST; Griff D; Joyner CM; Ellinwood EH; Nemeroff CB
Neuropsychopharmacology; 1993 May; 8(3):259-65. PubMed ID: 8507352
[TBL] [Abstract][Full Text] [Related]
12. Transient amelioration of the sensitization of cocaine-induced behaviors in rats by the induction of tolerance.
Dalia AD; Norman MK; Tabet MR; Schlueter KT; Tsibulsky VL; Norman AB
Brain Res; 1998 Jun; 797(1):29-34. PubMed ID: 9630493
[TBL] [Abstract][Full Text] [Related]
13. Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats.
Neisewander JL; Lucki I; McGonigle P
Pharmacol Biochem Behav; 1996 Apr; 53(4):935-42. PubMed ID: 8801600
[TBL] [Abstract][Full Text] [Related]
14. Dopamine efflux during withdrawal from continuous or intermittent cocaine.
King GR; Kuhn C; Ellinwood EH
Psychopharmacology (Berl); 1993; 111(2):179-84. PubMed ID: 7870949
[TBL] [Abstract][Full Text] [Related]
15. Behavioural consequences of cocaine withdrawal in rats.
Fung YK; Richard LA
J Pharm Pharmacol; 1994 Feb; 46(2):150-2. PubMed ID: 8021807
[TBL] [Abstract][Full Text] [Related]
16. Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats.
Rudoy CA; Van Bockstaele EJ
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1119-29. PubMed ID: 17513029
[TBL] [Abstract][Full Text] [Related]
17. Lack of behavioral sensitization to repeated cocaine administration from postnatal days 1 to 10.
Meyer JS; Yacht AC
Int J Neurosci; 1993 Sep; 72(1-2):107-13. PubMed ID: 8225794
[TBL] [Abstract][Full Text] [Related]
18. Continuous cocaine induces persisting changes in behavioral responsivity to both scopolamine and diazepam.
Lipton JW; Ellison GD
Neuropsychopharmacology; 1992 Sep; 7(2):143-8. PubMed ID: 1418303
[TBL] [Abstract][Full Text] [Related]
19. The effects of continuous cocaine dose, treatment, and withdrawal duration on the induction of behavioral tolerance and dopamine autoreceptor function.
King GR; Hillburn C; Pinto G; Konen J
Pharmacol Biochem Behav; 2004 Jun; 78(2):293-300. PubMed ID: 15219770
[TBL] [Abstract][Full Text] [Related]
20. Altered cocaine potency in the nucleus accumbens following 7-day withdrawal from intermittent but not continuous treatment: voltammetric assessment of dopamine uptake in the rat.
Lee TH; Gee KR; Ellinwood EH; Seidler FJ
Psychopharmacology (Berl); 1998 Jun; 137(3):303-10. PubMed ID: 9683008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
